Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD)
CUSIP: 74065P101
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 65,427,364
- Total 13F shares
- 34,651,491
- Share change
- +1,329,430
- Total reported value
- $2,474,382,581
- Price per share
- $71.55
- Number of holders
- 51
- Value change
- +$136,089,518
- Number of buys
- 37
- Number of sells
- 25
Quarterly Holders Quick Answers
What is CUSIP 74065P101?
CUSIP 74065P101 identifies PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74065P101:
Top shareholders of PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
24%
|
15,594,877
|
$469,874,000 | — | 30 Sep 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
15%
|
10,118,636
|
$304,875,000 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
4.8%
|
3,128,384
|
$90,109,000 | — | 30 Sep 2020 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
1.1%
|
750,000
|
$22,598,000 | — | 30 Sep 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.1%
|
726,463
|
$21,888,330 | — | 30 Sep 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.79%
|
518,011
|
$15,608,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.61%
|
400,000
|
$12,052,000 | — | 30 Sep 2020 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.55%
|
360,263
|
$10,855,000 | — | 30 Sep 2020 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
225,000
|
$6,779,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.29%
|
189,573
|
$5,712,000 | — | 30 Sep 2020 | |
| Woodline Partners LP |
13F
|
Company |
0.27%
|
179,361
|
$5,404,000 | — | 30 Sep 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.24%
|
155,690
|
$4,691,000 | — | 30 Sep 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.23%
|
150,000
|
$4,520,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.17%
|
110,915
|
$3,341,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
83,200
|
$2,507,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.1%
|
62,450
|
$1,881,000 | — | 30 Sep 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.09%
|
61,489
|
$1,853,000 | — | 30 Sep 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
54,066
|
$1,629,000 | — | 30 Sep 2020 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.08%
|
50,000
|
$1,507,000 | — | 30 Sep 2020 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.08%
|
50,000
|
$1,507,000 | — | 30 Sep 2020 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.07%
|
48,624
|
$1,465,000 | — | 30 Sep 2020 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.07%
|
45,360
|
$1,367,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.07%
|
45,000
|
$1,356,000 | — | 30 Sep 2020 | |
| Zimmer Partners, LP |
13F
|
Company |
0.06%
|
40,000
|
$1,205,000 | — | 30 Sep 2020 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.05%
|
34,383
|
$1,036,000 | — | 30 Sep 2020 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.05%
|
31,101
|
$937,000 | — | 30 Sep 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
22,509
|
$678,000 | — | 30 Sep 2020 | |
| NORGES BANK |
13F
|
Company |
0.03%
|
20,000
|
$603,000 | — | 30 Sep 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.03%
|
16,703
|
$503,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
13,155
|
$396,000 | — | 30 Sep 2020 | |
| Maven Securities LTD |
13F
|
Company |
0.01%
|
9,091
|
$264,000 | — | 30 Sep 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
7,375
|
$222,000 | — | 30 Sep 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
7,108
|
$214,000 | — | 30 Sep 2020 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0.01%
|
6,251
|
$188,000 | — | 30 Sep 2020 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.01%
|
5,000
|
$151,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,423
|
$43,000 | — | 30 Sep 2020 | |
| Jacobi Capital Management LLC |
13F
|
Company |
0%
|
500
|
$15,000 | — | 30 Sep 2020 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
100
|
$3,000 | — | 30 Sep 2020 |
Institutional Holders of Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) as of Q4 2020
As of 31 Dec 2020,
Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,651,491 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, FMR LLC, HILLHOUSE CAPITAL ADVISORS, LTD., VANGUARD GROUP INC, BlackRock Inc., UBS ASSET MANAGEMENT AMERICAS INC, PRICE T ROWE ASSOCIATES INC /MD/, Rock Springs Capital Management LP, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
38
Q4 2020 holders
51
Holder diff
13
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.